Liver malignancies [neop]    
interstitial [blor]    
High dose rate brachytherapy [qnco]    
Complications [patf]    
Risk Factors [qnco]    
Evaluate [hlca]    
Complications [patf]    
Risk Factors [qnco]    
adverse events [patf]    
Patients [podg]    
Brachytherapy, interstitial [topp]    
Material [sbst]    
Methods [inpr]    
Patients [podg]    
Treated [ftcn]    
CT [geoa]    
MRI [diap]    
guided intervention [hlca]    
Large tumour [qlco]    
Treated [ftcn]    
Patients [podg]    
Tumors [neop]    
Patients [podg]    
Chemotherapy [topp]    
liver resection [topp]    
Thermoablation [topp]    
Transarterial embolisation [topp]    
chemo [topp]    
Safety [hcpp]    
Primary Endpoint [irda]    
Survival [acty]    
Obtained [ftcn]    
secondary [neop]    
endpoints [qlco]    
MRI [diap]    
CT [geoa]    
Imaging [diap]    
Performed [ftcn]    
Parameters [fndg]    
Obtained [ftcn]    
Complications [patf]    
Five [qnco]    
BLEEDING [patf]    
Occurred [acty]    
Frequency [qnco]    
SEVERE [qlco]    
BLEEDING [patf]    
Significantly high [qnco]    
Patients [podg]    
Advanced Liver Cirrhosis [dsyn]    
signs [ftcn]    
radiation disease [dsyn]    
Induced [ftcn]    
LIVER [bpoc]    
Patients [podg]    
Symptomatic [ftcn]    
Gastrointestinal Ulcers [dsyn]    
Detected [fndg]    
DOSE [qnco]    
Exposure NOS [inpo]    
Gastrointestinal [spco]    
Wall [mnob]    
GY [geoa]    
reliable [inpr]    
THRESHOLD [qlco]    
ULCER [dsyn]    
formation [biof]    
Combination [qlco]    
mg/L [qnco]    
Leukocyte Count [lbpr]    
Second [qnco]    
intervention [hlca]    
Predicted [idcn]    
SENSITIVITY SPECIFICITY [qnco]    
>90 [qnco]    
Patients [podg]    
Died [orgf]    
30 days [tmco]    
Median [spco]    
Survival [acty]    
Hepatic Treatment [topp]    
Patients [podg]    
LOCAL [spco]    
free [ftcn]    
SURVIVE [phsu]    
Proportion [qnco]    
Conclusions [idcn]    
Image [inpr]    
Guide [prog]    
Low [qlco]    
Complications [patf]    
effective [qlco]    
